Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release

Cell Death and Disease

Volumn 4, Issue 2, 2013, Pages

  Marques, C ^a   Oliveira, C S F ^a   Alves, S ^a   Chaves, S R ^a   Coutinho, O P ^a   Corte Real M ^a   Preto, A ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Acetate; Apoptosis; Cathepsin D; Colorectal carcinoma; Lysosomal membrane permeabilization (LMP)

Indexed keywords

ACETIC ACID; ALOXISTATIN; CATHEPSIN D; PEPSTATIN;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL PERMEABILIZATION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; LYSOSOME MEMBRANE; PRIORITY JOURNAL;

ACETIC ACID; APOPTOSIS; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; COLORECTAL NEOPLASMS; HUMANS; HYDROGEN-ION CONCENTRATION; LEUCINE; LYSOSOMES; PEPSTATINS;

SACCHAROMYCES CEREVISIAE;

EID: 84875984111     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.29     Document Type: Article

References (42)

1. Lan A, Lagadic-Gossmann D, Lemaire C, Brenner C, Jan G. Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis 2007; 12: 573-591.
2. Ruemmele FM, Schwartz S, Seidman EG, Dionne S, Levy E, Lentze MJ. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut 2003; 52: 94-100.
3. Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G et al. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 2002; 9: 179-188.
4. Lan A, Bruneau A, Bensaada M, Philippe C, Bellaud P, Rabot S et al. Increased induction of apoptosis by Propionibacterium freudenreichii TL133 in colonic mucosal crypts of human microbiota-associated rats treated with 1,2-dimethylhydrazine. Br J Nutr 2008; 100: 1251-1259.
5. Lan A, Bruneau A, Philippe C, Rochet V, Rouault A, Herve C et al. Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats. Br J Nutr 2007; 97: 714-724.
6. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2002; 132: 1012-1017.
7. Guicciardi ME, Leist M, Gores GJ. Lysosomes in cell death. Oncogene 2004; 23: 2881-2890.
8. Kagedal K, Johansson AC, Johansson U, Heimlich G, Roberg K, Wang NS et al. Lysosomal membrane permeabilization during apoptosis-involvement of Bax? Int J Exp Pathol 2005; 86: 309-321.
9. Tardy C, Codogno P, Autefage H, Levade T, Andrieu-Abadie N. Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochim Biophys Acta Rev Cancer 2006; 1765: 101-125.
10. Kirkegaard T, Jaattela M. Lysosomal involvement in cell death and cancer. Biochim Biophys Acta Mol Cell Res 2009; 1793: 746-754.
11. Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006; 6: 764-775.
12. Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai F-Y et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004; 5: 443-453.
13. Palermo C, Joyce JA. Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci 2008; 29: 22-28.
14. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007; 7: 800-808.
15. Nicotra G, Castino R, Follo C, Peracchio C, Valente G, Isidoro C. The dilemma: does tissue expression of cathepsin D reflect tumor malignancy? The question: does the assay truly mirror cathepsin D mis-function in the tumor? Cancer Biomark 2010; 7: 47-64.
16. Iacobuzio-Donahue C, Shuja S, Cai J, Peng P, Willett J, Murnane MJ. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function. Int J Oncol 2004; 24: 473-485.
17. Yilmaz F, Uzunlar AK, Kilinc N, Yilmaz HG. Expression of cathepsin D in colorectal adenocarcinomas: correlation with clinicopathologic features. Ann Saudi Med 2003; 23: 208-211.
18. Pereira C, Chaves S, Alves S, Salin B, Camougrand N, Manon S et al. Mitochondrial degradation in acetic acid-induced yeast apoptosis: the role of Pep4 and the ADP/ATP carrier. Mol Microbiol 2010; 76: 1398-1410.
19. Groth-Pedersen L, Ostenfeld MS, Hoyer-Hansen M, Nylandsted J, Jaattela M. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 2007; 67: 2217-2225.
20. Fehrenbacher N, Bastholm L, Kirkegaard-Sørensen T, Rafn B, Bøttzauw T, Nielsen C et al. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res 2008; 68: 6623-6633.
21. Emert-Sedlak L, Shangary S, Rabinovitz A, Miranda MB, Delach SM, Johnson DE. Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Mol Cancer Ther 2005; 4: 733-742.
22. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361: 1496-1501.
23. Britz T, Steyn P. Volatile fatty acid production by the dairy and clinical propionibacteria and related coryneforms. Phytophylactica 1979; 11: 111-115.
24. Titus E, Ahearn GA. Short-chain fatty acid transport in the intestine of a herbivorous teleost. J Exp Biol 1988; 135: 77-94.
25. Scharrer E, Amstutz I, Grenacher B. Inhibition of mucosal glycylsarcosine uptake by acetate in rat distal small intestine. Exp Physiol 1999; 84: 541-548.
26. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oresic K et al. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002; 383: 1035-1044.
27. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008; 27: 6434-6451.
28. Trincheri NF, Nicotra G, Follo C, Castino R, Isidoro C. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. Carcinogenesis 2007; 28: 922-931.
29. Kagedal K, Johansson U, Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 2001; 15: 1592-1594.
30. Johansson AC, Steen H, Ollinger K, Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 2003; 10: 1253-1259.
31. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996; 15: 3861-3870.
32. Chen QY, Shi JG, Yao QH, Jiao DM, Wang YY, Hu HZ et al. Lysosomal membrane permeabilization is involved in curcumin-induced apoptosis of A549 lung carcinoma cells. Mol Cell Biochem 2012; 359: 389-398.
33. Li LJ, Zhong LF, Jiang LP, Geng CY, Zhu TZ, Xu YH et al. Lysosomal membrane permeabilization contributes to elemene emulsion-induced apoptosis in A549 cells. Free Radic Res 2011; 45: 1232-1240.
34. Carmona-Gutierrez D, Bauer MA, Ring J, Knauer H, Eisenberg T, Buttner S et al. The propeptide of yeast cathepsin D inhibits programmed necrosis. Cell Death Dis 2011; 2: e161.
35. Mayer A, Fritz E, Fortelny R, Kofler K, Ludwig H. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer. Cancer Invest 1997; 15: 106-110.
36. Beaujouin M, Liaudet-Coopman E. Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependent chemo-sensitivity independently of its catalytic activity. Adv Exp Med Biol 2008; 617: 453-461.
37. Kunimura T, Inagaki T, Wada M, Ushio J, Sato K, Enosawa T et al. Immunohistochemical evaluation of tissue-specific proteolytic enzymes in adenomas containing foci of early carcinoma: correlations with cathepsin D expression and other malignant features. Int J Gastrointest Cancer 2003; 33: 149-154.
38. Kanber Y, Demirbag NR, Sam AD, Aydin N. Cathepsin D expression in colorectal adenocarcinomas and adenomas. Int J Biol Markers 2002; 17: 165-168.
39. Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, Zwierz K. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Hepatogastroenterology 2008; 55: 388-393.
40. Arao J, Fukui H, Ono Y, Ueda Y, Chiba T, Fujimori T. Immunohistochemical localization of cathepsin D in colorectal tumors. Dis Colon Rectum 2000; 43: 396-401.
41. Theodoropoulos GE, Panoussopoulos D, Lazaris AC, Golematis BC. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma. J Surg Oncol 1997; 65: 242-248.
42. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 1996; 32: 315-317.